Download: WDA Whitepaper – 5 Steps To Obtaining A WDA (A Wholesale Distribution Authorisation)

The WDA process is complex.  Indeed, many companies turn to us to manage the application process on their behalf. In our updated WDA whitepaper, 5 Steps To Obtaining A Wholesale Distribution Authorisation, we have highlighted 5 steps that companies must undertake if they want to secure a Wholesale Distribution Authorisation licence.

WDA e-book 2018 Acorn Regulatory

Our Wholesale Distribution Authorisation team works in the area day-in and day-out with companies from all over the world.  They ensure that the client secures their Wholesale Distribution Authorisation in a timely and cost effective manner.

In this WDA whitepaper we look at the 5 steps to obtaining a WDA (Wholesale Distribution Authorisation) for your company.

The document, written by Acorn Regulatory expert staff looks at:

a. Defining the supply chain

b. Implementing a Quality Management System

c. The role of the RP

d. Submitting the Wholesale Distribution Authorisation application

e. The HPRA inspection (or inspection by a similar body such as the MHRA)

In short,  a WDA is required in order to conduct wholesale activities of medicinal products. Our team will provide the required support, knowledge, experience and tools to ensure your organisation secures a WDA from the Health Products Regulatory Authority (HPRA).

Acorn Regulatory has worked with numerous companies on issues relating to Wholesale Distribution Authorisations.  Read more about our WDA services here.

Download the updated 2018 WDA whitepaper by completing your details below.

This whitepaper has been downloaded thousands of times by companies taking steps to obtaining a WDA and an understanding of the Wholesale Distribution Authorisation process.  Download it today and contact us to see how we can help your company to secure a WDA.

Read more of our publications here.


About the Author
Gemma Robinson, PhD
Managing Director
As Managing Director of Acorn Regulatory, Gemma Robinson is actively involved on client projects on a day to day basis and she leads a team of respected pharmaceutical, medical device, pharmacovigilance and clinical trial experts.  Gemma is also an active contributor to developing and promoting standards in the regulatory affairs profession and she has worked with a number of academic and not for profit organisations to encourage individuals to pursue a career in regulatory affairs and the broader STEM subjects. You can read more articles by Gemma by clicking the link below.
Other articles by Gemma Robinson PhD